Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program
Falcón Lincheta, Leopoldina, Saumell Nápoles, Yaimarelis, Gray Lovio, Olaine R., Viqueira Fuentesfría, Alina M., Pérez Alonso, Teresita, Batista Romagoza, Maritza, Urquiza Rodríguez, Aleida, Mantecón Fernández, Beatriz, Bautista Jerez, Heber A., Fernández de Armas, Damarys, Martínez Matute, Eldenida S., León García, Yakelin, Oramas Fernández, Diana K., Marrero Chavez, Yaneisy, Fernandez Lorente, Aymara, Valls Hung, Ana R., Lorenzo-Luaces, Patricia, Valenzuela Silva, Carmen, Moreno, Ernesto, Hernández-Casaña, Patricia
Published in International immunopharmacology (15.06.2024)
Published in International immunopharmacology (15.06.2024)
Get full text
Journal Article